Architected to Replace Disconnected Point Solutions Through a Single Orchestrated AI Layer Across Clinical, Operational, and Financial Workflows.

NEW YORK CITY, NY / ACCESS Newswire / March 16, 2026 / CureMD today announced the launch of 11x, its next-generation AI-native healthcare operating system purpose-built to transform how enterprise healthcare organizations deliver care, scale operations, and capture revenue.

The launch marks a strategic milestone in CureMD's long-term AI roadmap. Since 2022, the company has systematically invested in applied artificial intelligence, publishing 13 research studies and engineering a coordinated intelligence architecture designed for measurable, enterprise-wide productivity gains.

At the core, 11x comprises of 16 production-grade AI models, unified within a single operating layer spanning across clinical, operational, and financial domains. Unlike feature-based AI solutions that address challenges in silos, 11x is architected from the ground up to create structural alignment across workflows, reducing fragmentation, lowering administrative burden, and increasing revenue precision.

The platform advances:

• Clinical performance through specialty-aware ambient intelligence and real-time reasoning

• Operational throughput via predictive workflow orchestration

• Financial integrity from documentation to reimbursement, including denial prediction and revenue optimization

Designed for scalability, 11x delivers advanced usability across web, mobile, and voice, enabling natural enterprise-wide adoption without workflow disruption.

By integrating longitudinal data foundations, governance-aware AI execution, and coordinated reasoning frameworks, CureMD is positioning AI not as an overlay but as core healthcare infrastructure.

"Healthcare's next phase will not be defined by incremental automation, but by coordinated intelligence," said Bilal Hashmat, CEO of CureMD. "Since 2022, we have been building the foundational architecture required to unify clinical excellence, operational scale, and financial performance. 11x transforms AI from isolated capabilities into a systemic operating layer; creating structural operating leverage and measurable productivity gains for healthcare enterprises."

With 11x, CureMD reinforces its position as a long-term AI infrastructure partner to enterprise healthcare organizations navigating rising cost pressures, workforce shortages, and margin compression.

Following a highly successful unveiling at HIMSS26, 11x is now available for deployment across enterprise healthcare environments.

About CureMD

CureMD is a leading provider of enterprise-grade, AI-native healthcare technology solutions. With over 29 years of experience, CureMD has helped practices across 33+ specialties streamline and optimize their operations at scale. The company delivers a unified platform spanning EHR, practice management, RCM, and patient engagement, purpose-built for clinical excellence, operational efficiency, and financial performance. Trusted by 40,000+ providers, processing over $5B in annual revenue, CureMD is committed to making advanced AI infrastructure accessible to health systems and underserved communities nationwide.

Learn more at curemd.com

Media Contact:
Adam Hashmat
CureMD Healthcare
+1 866-643-8367
sales@curemd.com

SOURCE: CureMD